Shukra Pharmaceuticals standalone net profit rises 544.30% in the December 2025 quarter
Sales rise 269.85% to Rs 39.13 crore
Net profit of Shukra Pharmaceuticals rose 544.30% to Rs 20.36 crore in the quarter ended December 2025 as against Rs 3.16 crore during the previous quarter ended December 2024. Sales rose 269.85% to Rs 39.13 crore in the quarter ended December 2025 as against Rs 10.58 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales39.1310.58 270 OPM %69.3137.15 -PBDT27.664.79 477 PBT26.824.09 556 NP20.363.16 544Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 04 2026 | 6:17 PM IST